Value 40%
How cheap is EXEL compared to other Healthcare stocks? Lower forward P/E, EV/EBITDA, and P/FCF earn higher Value scores.
73.7
- Forward P/E
- 15.40
- EV / EBITDA
- 12.50
- P / FCF
- 14.02
- PEG
- 0.25
EXEL Exelixis, Inc.
73.5
Opportunity
Raw BEACON composite
How to read this page
The big number above is EXEL's BEACON composite — a 0-100 sector-relative score blending three factors: Value (40%), Quality (35%), and Momentum (25%). A score of 70+ means EXEL ranks well against its Healthcare peers on most factors. The current macro regime is then overlaid to produce the regime-adjusted score lower on this page.
Every metric on this page is computed against Healthcare peers, not the whole market. A "cheap" P/E in tech isn't the same as a "cheap" P/E in utilities. Read the full methodology →
Quality 35%
How healthy is the underlying business? Higher gross margin, ROE, and FCF yield (and lower debt) earn higher Quality scores.
84.7
- Gross Margin
- +96.4%
- ROE
- +36.2%
- Debt / Equity
- 0.08
- FCF Yield
- +7.13%
Momentum 25%
Is the market starting to recognize the value? Above the 200-day moving average and a positive 3-month return earn higher Momentum scores.
57.7
- Price
- $45.41
- 200-day SMA
- $41.59
- vs 200-day
- +9.2%
- 3-month change
- +3.1%
EXEL vs Healthcare Median
Each row compares EXEL to the median stock in the Healthcare sector. ▲ Better means EXEL is better positioned than the sector median for that metric (cheaper for valuation metrics, healthier for quality metrics). ▼ Worse means the opposite. Tiny differences (within 2%) are shown as In line.
| Metric | EXEL | Healthcare Median | vs Median |
|---|---|---|---|
| Forward P/E | 15.40 | 11.87 | ▼ Worse |
| EV / EBITDA | 12.50 | 9.00 | ▼ Worse |
| P / FCF | 14.02 | 10.33 | ▼ Worse |
| PEG Ratio | 0.25 | 0.09 | ▼ Worse |
| Gross Margin | +96.4% | +64.2% | ▲ Better |
| ROE | +36.2% | -6.6% | ▲ Better |
| Debt / Equity | 0.08 | 0.27 | ▲ Better |
| FCF Yield | +7.1% | +0.9% | ▲ Better |
Regime Fit
The current macro regime favors some sectors and pressures others. BEACON multiplies EXEL's raw score by a sector-specific multiplier to produce its regime-adjusted score. The regime contribution below is how many score points the overlay added (or subtracted) for this stock.
Current regimeEXPANSION
Confidence70.0%
Fit► Neutral
Base multiplier1.00x
Effective multiplier1.00x
Regime contribution0.0 pts
Raw BEACON73.5
Regime-adjusted73.5
Global rank#26
Sector rank#3 / 150
Financial Health
These five indicators drive BEACON's hard red-flag gates. If any of them lands in the red zone, the composite score is capped at 40 regardless of how the Value/Quality/Momentum sub-scores look. Refreshed weekly from EXEL's most recent annual filings.
Altman Z-Score
12.65
Safe Zone
≥ 3.0 safe · 1.81-2.99 grey · < 1.8 distress
Current Ratio
3.56
Healthy
≥ 1.5 healthy · 1.0-1.49 adequate · < 0.5 critical
Revenue YoY Growth
+7.0%
Growing
≥ +5% growing · 0 to -15% declining · < -15% sharp
Consecutive Negative FCF Years
0
None
3+ years triggers a red flag
Consecutive Revenue Decline Years
0
None
2+ years (combined w/ -15% YoY) triggers a red flag
Interested in gold & mining?
GoldStockData rates 850+ precious metals miners on 11 quantitative signal layers.
Visit GoldStockData →